These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35663436)

  • 21. Persistent Postprandial Regurgitation vs Rumination in Patients With Refractory Gastroesophageal Reflux Disease Symptoms: Identification of a Distinct Rumination Pattern Using Ambulatory Impedance-pH Monitoring.
    Nakagawa K; Sawada A; Hoshikawa Y; Nikaki K; Sonmez S; Woodland P; Yazaki E; Sifrim D
    Am J Gastroenterol; 2019 Aug; 114(8):1248-1255. PubMed ID: 31246694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Esophageal pH Monitoring to Minimize Proton-Pump Inhibitor Utilization in Patients with Gastroesophageal Reflux Symptoms.
    Triadafilopoulos G; Zikos T; Regalia K; Sonu I; Fernandez-Becker NQ; Nguyen L; Nandwani MCR; Clarke JO
    Dig Dis Sci; 2018 Oct; 63(10):2673-2680. PubMed ID: 29959725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
    Lacy BE; Chehade R; Crowell MD
    Am J Gastroenterol; 2011 Sep; 106(9):1604-11. PubMed ID: 21691342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mean Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index Could Identify Gastroesophageal Reflux Disease but pH-Impedance Metrics Alone Might Not Correlate With Proton Pump Inhibitor Response in Chinese Patients With Typical Reflux Symptoms.
    Wang D; Duan C; Zhang X; Xu J; Hou X; Xiang X
    J Neurogastroenterol Motil; 2022 Oct; 28(4):580-588. PubMed ID: 36250365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modern diagnosis of GERD: the Lyon Consensus.
    Gyawali CP; Kahrilas PJ; Savarino E; Zerbib F; Mion F; Smout AJPM; Vaezi M; Sifrim D; Fox MR; Vela MF; Tutuian R; Tack J; Bredenoord AJ; Pandolfino J; Roman S
    Gut; 2018 Jul; 67(7):1351-1362. PubMed ID: 29437910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptoms, the GerdQ score and patients' characteristics do not predict gastroesophageal reflux disease in patients with proton-pump-inhibitor-refractory reflux symptoms-results from a large prospective database.
    Labenz J; Menzel M; Hirsch O; Müller M; Labenz C; Adarkwah CC
    PeerJ; 2023; 11():e14802. PubMed ID: 36846452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An analysis of 342 patients with refractory gastroesophageal reflux disease symptoms using questionnaires, high-resolution manometry, and impedance-pH monitoring.
    Wang F; Li P; Ji GZ; Miao L; Fan Z; You S; Pan X; Chen X
    Medicine (Baltimore); 2017 Feb; 96(5):e5906. PubMed ID: 28151867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Number of reflux episodes on pH-impedance monitoring associates with improved symptom outcome and treatment satisfaction in gastro-oesophageal reflux disease (GERD) patients with regurgitation.
    Rogers BD; Valdovinos LR; Crowell MD; Bell R; Vela MF; Gyawali CP
    Gut; 2021 Mar; 70(3):450-455. PubMed ID: 32467089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastroesophageal reflux disease and chronic cough: A possible mechanism elucidated by ambulatory pH-impedance-pressure monitoring.
    Li X; Lin S; Wang Z; Zhang H; Sun X; Li J; Wu D; Ke M; Fang X
    Neurogastroenterol Motil; 2019 Dec; 31(12):e13707. PubMed ID: 31482661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophageal contractile segment impedance from high-resolution impedance manometry correlates with mean nocturnal baseline impedance and acid exposure time from 24-hour pH-impedance monitoring.
    Horton A; Posner S; Sullivan B; Cornejo J; Davis A; Fields M; McIntosh T; Gellad Z; Shimpi R; Gyawali CP; Patel A
    Dis Esophagus; 2020 Dec; 33(12):. PubMed ID: 32607563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring gastroesophageal reflux disease: relationship between the Health-Related Quality of Life score and physiologic parameters.
    Velanovich V; Karmy-Jones R
    Am Surg; 1998 Jul; 64(7):649-53. PubMed ID: 9655276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On-therapy impedance-pH monitoring can efficiently characterize PPI-refractory GERD and support treatment escalation.
    Frazzoni M; Frazzoni L; Ribolsi M; Russo S; Conigliaro R; De Bortoli N; Savarino E
    Neurogastroenterol Motil; 2023 May; 35(5):e14547. PubMed ID: 36780512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.
    Becker V; Grotz S; Schlag C; Nennstiel S; Beitz A; Haller B; Schmid RM; Meining A; Bajbouj M
    World J Gastroenterol; 2014 Apr; 20(14):4017-24. PubMed ID: 24744591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of
    Zhao T; Liu F; Li Y
    Front Cell Infect Microbiol; 2023; 13():1082620. PubMed ID: 36968099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esophageal symptoms versus epigastric symptoms: Relevance for diagnosis of gastroesophageal reflux disease.
    Zhang MY; Tan ND; Li YW; Sifrim D; Pandolfino JE; Xiao YL; Chen MH
    J Dig Dis; 2020 Dec; 21(12):696-704. PubMed ID: 32975045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the Korean Version of the Gastroesophageal Reflux Disease Questionnaire for the Diagnosis of Gastroesophageal Reflux Disease.
    Gong EJ; Jung KW; Min YW; Hong KS; Jung HK; Son HJ; Kim DY; Lee J; Lee OY
    J Neurogastroenterol Motil; 2019 Jan; 25(1):91-99. PubMed ID: 30646480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Open access capture of patients with gastroesophageal reflux disease using an online patient-reported outcomes instrument.
    Tielemans MM; Jansen JB; van Oijen MG
    Interact J Med Res; 2012 Sep; 1(2):e7. PubMed ID: 23611985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastroesophageal reflux disease and salivary pepsin in patients with heterotopic gastric mucosa in the upper esophagus.
    Xiong X; He S; Xu F; Xu Z; Zhang X; Wang H; Liu T; Jia Y
    Dis Esophagus; 2022 Apr; 35(4):. PubMed ID: 34750620
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.